BKK:VIH-R (Thailand)
Â
Units Non-Voting Depository Receipts
฿
8.95
(0%)
Aug 7
Business Description
Srivichaivejvivat PCL
Share Class Description:
BKK:VIH-R: Units Non-Voting Depository ReceiptsCompare
Compare
Traded in other countries / regions
VIH.Thailand IPO Date
2012-05-09Description
Srivichaivejvivat PCL is engaged in hospital business. The company provides 24-hour medical treatment by specialized doctors, with services in the outpatient department (OPD) by specialized doctors until midnight. Specialized clinics are available, such as comprehensive laparoscopic surgery, orthopedic surgery, urology, vascular surgery, cardiology, nephrology and hemodialysis center, endocrinology, neurology, gastroenterology, pediatric clinic, obstetrics and gynecology clinic, emergency accident center, dental center, health check-up center, Thai Filos Anti-Aging Center. It operates in single segment of hospital business in Thailand only.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 22 |
N/A
|
N/A
| |||
Equity-to-Asset | 0.86 |
N/A
|
N/A
| |||
Debt-to-Equity | 0.02 |
N/A
|
N/A
| |||
Debt-to-EBITDA | 0.09 |
N/A
|
N/A
| |||
Interest Coverage | 133.29 |
N/A
|
N/A
| |||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 7.85 | |||||
Beneish M-Score | -2.54 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -7.7 | |||||
3-Year EBITDA Growth Rate | -13.2 |
N/A
|
N/A
| |||
3-Year EPS without NRI Growth Rate | -16.5 |
N/A
|
N/A
| |||
3-Year FCF Growth Rate | -3.8 |
N/A
|
N/A
| |||
3-Year Book Growth Rate | 6.6 |
N/A
|
N/A
|
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
9-Day RSI | 43.96 |
N/A
|
N/A
| |||
14-Day RSI | 51.69 |
N/A
|
N/A
| |||
6-1 Month Momentum % | 8.48 |
N/A
|
N/A
| |||
12-1 Month Momentum % | 24 |
N/A
|
N/A
|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.73 |
N/A
|
N/A
| |||
Quick Ratio | 4.57 |
N/A
|
N/A
| |||
Cash Ratio | 3.21 |
N/A
|
N/A
| |||
Days Inventory | 9.47 |
N/A
|
N/A
| |||
Days Sales Outstanding | 42.95 |
N/A
|
N/A
| |||
Days Payable | 57.51 |
N/A
|
N/A
|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Payout Ratio | 0.56 |
N/A
|
N/A
| |||
3-Year Dividend Growth Rate | -20.6 |
N/A
|
N/A
| |||
3-Year Average Share Buyback Ratio | -2.2 |
N/A
|
N/A
| |||
Shareholder Yield % | 4.56 |
N/A
|
N/A
|
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 27.62 |
N/A
|
N/A
| |||
Operating Margin % | 17.65 |
N/A
|
N/A
| |||
Net Margin % | 14.09 |
N/A
|
N/A
| |||
EBITDA Margin % | 23.88 |
N/A
|
N/A
| |||
FCF Margin % | 12.1 |
N/A
|
N/A
| |||
OCF Margin % | 17.86 |
N/A
|
N/A
| |||
ROE % | 11.68 |
N/A
|
N/A
| |||
ROA % | 10.07 |
N/A
|
N/A
| |||
ROIC % | 16.74 |
N/A
|
N/A
| |||
3-Year ROIIC % | -61.1 |
N/A
|
N/A
| |||
ROC (Joel Greenblatt) % | 23.8 |
N/A
|
N/A
| |||
ROCE % | 14.15 |
N/A
|
N/A
| |||
Years of Profitability over Past 10-Year | 10 |
N/A
|
N/A
|
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 12.52 |
N/A
|
N/A
| |||
Forward PE Ratio | 15.98 |
N/A
|
N/A
| |||
PE Ratio without NRI | 12.61 |
N/A
|
N/A
| |||
Price-to-Owner-Earnings | 20.72 |
N/A
|
N/A
| |||
PS Ratio | 1.76 |
N/A
|
N/A
| |||
PB Ratio | 1.39 |
N/A
|
N/A
| |||
Price-to-Tangible-Book | 1.39 |
N/A
|
N/A
| |||
Price-to-Free-Cash-Flow | 14.6 |
N/A
|
N/A
| |||
Price-to-Operating-Cash-Flow | 9.89 |
N/A
|
N/A
| |||
EV-to-EBIT | 7.59 |
N/A
|
N/A
| |||
EV-to-EBITDA | 5.65 |
N/A
|
N/A
| |||
EV-to-Forward-EBITDA | 4.34 |
N/A
|
N/A
| |||
EV-to-Revenue | 1.35 |
N/A
|
N/A
| |||
EV-to-Forward-Revenue | 1.08 |
N/A
|
N/A
| |||
EV-to-FCF | 11.16 |
N/A
|
N/A
| |||
Price-to-GF-Value | 1.06 |
N/A
|
N/A
| |||
Price-to-Projected-FCF | 0.79 |
N/A
|
N/A
| |||
Price-to-Median-PS-Value | 1.06 |
N/A
|
N/A
| |||
Price-to-Graham-Number | 0.88 |
N/A
|
N/A
| |||
| Price-to-Net-Current-Asset-Value | 3.48 |
N/A
|
N/A
| |||
| Price-to-Net-Cash | 6.3 |
N/A
|
N/A
| |||
Earnings Yield (Greenblatt) % | 13.18 |
N/A
|
N/A
| |||
FCF Yield % | 6.69 |
N/A
|
N/A
| |||
Forward Rate of Return (Yacktman) % | -5.82 |
N/A
|
N/A
|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Srivichaivejvivat PCL Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ฿) | 3,099.66 | ||
| EPS (TTM) (฿) | 0.72 | ||
| Beta | 0.36 | ||
| 3-Year Sharpe Ratio | 0.08 | ||
| 3-Year Sortino Ratio | 0.14 | ||
| Volatility % | 16.6 | ||
| 14-Day RSI | 51.69 | ||
| 14-Day ATR (฿) | - | ||
| 20-Day SMA (฿) | 8.95 | ||
| 12-1 Month Momentum % | 24 | ||
| 52-Week Range (฿) | 7.25 - 9.25 | ||
| Shares Outstanding (Mil) | 626.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Srivichaivejvivat PCL Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Srivichaivejvivat PCL Stock Events
| Event | Date | Price (฿) | ||
|---|---|---|---|---|
| THB 0.400000 Cash Dividend | 2026-03-13 | 9.20 (+0.00%) | ||
| THB 0.250000 Cash Dividend | 2025-03-13 | 7.29 (+0.00%) | ||
| 1.06667:1 Stock Split | 2014-10-24 | -- |
Show
Entries
Srivichaivejvivat PCL Frequently Asked Questions
What is Srivichaivejvivat PCL(BKK:VIH-R)'s stock price today?
The current price of BKK:VIH-R is ฿8.95. The 52 week high of BKK:VIH-R is ฿9.25 and 52 week low is ฿7.25.
When is next earnings date of Srivichaivejvivat PCL(BKK:VIH-R)?
The next earnings date of Srivichaivejvivat PCL(BKK:VIH-R) is .
Does Srivichaivejvivat PCL(BKK:VIH-R) pay dividends? If so, how much?
Srivichaivejvivat PCL(BKK:VIH-R) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Srivichaivejvivat PCL
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers